Sort
40,608 grants matching “prostate cancer”
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$639,074Michael M. Shen · Columbia University Health Sciences · P01 · FY2022 · CA
ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy
$639,000David A. Benaron · Spectros Corporation · R01 · FY2010 · CA
HUMAN MUC1 ONCOPTOTEIN IS OF FUNCATIONAL IMPORTANCE TO THE DEVELOPMENT OF PROSTATE CANCER
$638,998Dana-Farber Cancer Institute, Inc. · · FY2008 · Department of the Army
HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER
$638,811Benjamin M Craig · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
PLASMA ANGIOME AND SERUM ANDROGENS AS PREDICTORS OF OVERALL SURVIVAL IN METASTATIC PROSTATE CANCER
$638,787Duke University · · FY2018 · Defense Health Agency
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
$638,683Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$638,665Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2020 · CA
Application of MAGNet Tools to Gene Regulatory Networks in Cancer
$638,491Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Cell free nucleic acid-based biomarkers in advanced prostate cancer
$638,405Liang Wang · Medical College Of Wisconsin · R01 · FY2018 · CA
Chip-Scale Intraoperative Optical Navigation with Immunotargeted Upconverting Nanoparticles
$638,388Mekhail Anwar · University Of California, San Francisco · R01 · FY2025 · CA
Culturally Adapted Cognitive Behavioral Stress and Self-Management (C-CBSM) Intervention for PC
$638,319Frank J Penedo · Northwestern University At Chicago · R01 · FY2017 · CA
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)
$638,257Jim Hu · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
MELT: Modulation of PSMA Expression for Lutetium Therapy
$638,248Thomas Hope · University Of California, San Francisco · R01 · FY2022 · CA
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches
$637,936Joseph Edward Ippolito · Washington University · R01 · FY2023 · CA
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate
$637,906Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2021 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies
$637,795Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Genetic determinants of gene expression phenotypes in aggressive prostate cancer
$637,767Liang Wang · Medical College Of Wisconsin · R01 · FY2011 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
$637,735David Basanta Gutierrez · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
PSMA-PET to Guide Prostatectomy: Can PSMA-PET Appropriately Modify Surgery, Reduce Nerve Damage and Optimize Quality-of-Life?
$637,698Clinton David Bahler · Indiana University Indianapolis · R01 · FY2022 · CA
Phase III Trial of Selenium for Prostate Cancer Prevention
$637,649University Of Arizona · R01 · FY2005 · CA
Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring
$637,566John Kurhanewicz · University Of California, San Francisco · R01 · FY2019 · CA
Genetics Variants in the Genome Predisposing to Aggressive PCa
$637,540William B Isaacs · Johns Hopkins University · R01 · FY2009 · CA
CHOLESTEROL PROMOTES REPROGRAMMING OF PROSTATE CANCER PROGRESSION AND METASTASIS
$637,501Cedars-Sinai Medical Center · · FY2018 · Department of the Army
PRECLINICAL ASSESSMENT OF BMX/ETK INHIBITORS FOR PROSTATE CANCER
$637,500Beth Israel Deaconess Medical Center, Inc. · · FY2009 · Department of the Army
IDENTIFICATION AND TARGETING OF UPSTREAM TYROSINE KINASES MEDIATING P13 KINASE ACTIVATION IN PTEN-DEFICIENT PROSTATE CANCER
$637,500Beth Israel Deaconess Medical Center, Inc. · · FY2008 · Department of the Army